SOPHiA GENETICS (SOPH) Research & Development (2020 - 2026)

SOPHiA GENETICS has disclosed Research & Development across 7 years of filings, most recently posting -$8.7 million for Q2 2026.

• In Q2 2026, Research & Development fell 2.8% year-over-year to -$8.7 million; the TTM figure through Jun 2026 stood at -$34.8 million (changed 0.49% YoY), while the FY2025 annual figure was -$34.2 million, changed 0.44% from the prior year.
• Research & Development came in at -$8.7 million for Q2 2026 at SOPHiA GENETICS, up from -$9.5 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of -$6.8 million in Q4 2022 to a low of -$10.1 million in Q3 2022.
• Average Research & Development over 5 years is -$8.8 million, with a median of -$9.0 million recorded in 2022.
• Year-over-year, Research & Development plunged 53.32% in 2022 and rose 12.36% in 2024.
• Over 5 years, Research & Development stood at -$6.8 million in 2022, then slumped by 43.73% to -$9.8 million in 2023, then advanced by 6.31% to -$9.1 million in 2024, then increased by 6.62% to -$8.5 million in 2025, then declined by 2.26% to -$8.7 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were -$8.7 million in Q2 2026, -$9.5 million in Q1 2026, and -$8.5 million in Q4 2025.